Weekly Market Outlook: MSCI Adds 33 Chinese Firms Including Z.AI, One of the 'Four GPU Dragons' Opens for Subscription

tags should appear inside. Do not use

tags. The output should be entirely plain HTML with

line breaks. No other formatting is allowed.

Upcoming economic data releases, a pivotal G20 finance leaders' gathering, fresh MSCI index adjustments, and a notable new share offering are set to drive market sentiment in the week ahead.

New purchasing managers' index (PMI) figures are scheduled for release, following the latest round of MSCI index changes that take effect at the close of trading on Monday. A leading domestic AI chip developer, often cited as one of the "Four GPU Dragons," will also open its initial public offering to investors this week.

Key Economic Data and Policy Events

The National Bureau of Statistics will publish the latest PMI data on Monday, August 31, followed by a report on price changes for essential production materials in the circulation sector on Friday, September 4.

Several new regulations take effect on September 1. The People's Bank of China, together with the State Administration for Market Regulation, has issued a joint notice prohibiting any individual or entity from illegally buying or selling RMB that is currently in circulation, with specific exceptions. These include RMB that has been officially withdrawn from circulation by the central bank, which may be traded from the date of withdrawal, and commemorative coins, which encompass both ordinary commemorative coins and precious metal commemorative coins. Ordinary commemorative coins, including commemorative coins and notes, cannot be traded in any form before they are made available to the public for exchange. Other circumstances stipulated by the central bank also apply.

Also effective September 1, the National Health Commission and two other departments will implement the 2026 edition of the National Essential Medicines List. The new list contains 794 drug varieties, an increase of 109 from the previous 685, aiming to better meet the public's basic medication needs for disease prevention and treatment.

The G20 Finance Ministers and Central Bank Governors Meeting will be held from August 31 to September 1 in Asheville, North Carolina, chaired by U.S. Treasury Secretary Scott Bessent. This marks Washington's first high-profile return to leading the multilateral agenda after skipping the South Africa-chaired G20 process last year.

The Shanghai Cooperation Organisation (SCO) Heads of State Council Meeting will take place in Bishkek on August 31 and September 1 under Kyrgyzstan's chairmanship. SCO Secretary-General Yermekbayev will attend the high-level event. Heads of state will review current international and regional hot-button issues and discuss prospects for multilateral cooperation across areas including political security, trade, transport, energy, digitalization, artificial intelligence, people-to-people exchanges, and sustainable development.

Market Index Adjustments and Contract Launches

The results of MSCI's August index review will take effect after the market close on Monday, August 31. The MSCI China Index will add 33 securities, including Z.AI, while removing 32 others, such as GCL Technology and Kingdee International. Of the 33 additions, 31 are A-share listings.

Coke options will begin trading on the Dalian Commodity Exchange starting Wednesday, September 2, with a call auction from 8:55 to 9:00 AM, followed by the market open at 9:00 AM. Night trading sessions for the contracts will also commence that evening.

Tesla Motors has announced via social media that it will hold a Cybercab launch event on September 3 in Austin, Texas.

Major Conferences and Industry Events

The 2026 World Power Battery Conference will take place from September 3 to 4 in Yibin, Sichuan Province, focusing on promoting global green and low-carbon sustainable development and accelerating high-quality growth in the power battery and new energy vehicle industries.

The 2026 China International Consumer Electronics Expo will be held from September 4 to 6 in Qingdao, themed "AI Leading, Smart Future," spotlighting the latest trends and frontiers in the global consumer electronics sector.

The 14th Semiconductor Equipment, Materials and Core Components Exhibition (CSEAC 2026) will run from August 31 to September 2 in Wuxi, covering more than 70,000 square meters of exhibition space. It will bring together over 1,300 domestic and international companies spanning wafer fabrication equipment, packaging and testing equipment, and core components and materials, with overseas exhibitors accounting for 16 percent of the total.

Lock-up Expirations and New Listings

Market data shows that 31 companies will see lock-up share expirations in the coming week (August 31 to September 6). Based on closing prices on August 28, the top three by market value of shares unlocked are 航天智造 (6.05 billion yuan), 宏和科技 (3.46 billion yuan), and 聚仁新材 (1.13 billion yuan). In terms of share volume, 航天智造 leads with 463 million shares, followed by 鸿特科技 with 144 million shares and 聚仁新材 with 97 million shares.

Three new stocks will be offered for subscription next week, according to public data, with two listed on the STAR Market and one on the Beijing Stock Exchange.

百迈科 is a high-tech enterprise specializing in the research, development, production, and sale of surgical medical devices, primarily surgical sutures, as well as peptide pharmaceutical equipment. Its main products include surgical sutures, interventional embolic materials, hemostatic materials, and peptide synthesis and cleavage instruments. The company's prospectus projects net profit attributable to parent shareholders of 54.5 million to 63.83 million yuan for the first three quarters of 2026, representing year-on-year growth of 0.39 percent to 17.57 percent.

燧原科技 is a leading player in China's cloud-based AI chip sector, dedicated to becoming a leader in general-purpose AI infrastructure. The company pursues a path of original innovation and independent research and development to build long-term sustainable competitiveness. Over its eight-year history, it has developed four generations of architecture across five cloud AI chips, establishing a complete product ecosystem covering AI chips, AI accelerator cards and modules, intelligent computing systems and clusters, and AI computing and programming software platforms. The company's prospectus forecasts revenue of 2.3 billion to 3.0 billion yuan for the first three quarters of 2026, up 325.78 percent to 455.36 percent year-on-year, with net losses attributable to parent shareholders narrowing to between 860 million and 700 million yuan.

信诺维 is an innovative pharmaceutical company focused on addressing major unmet clinical needs globally, committed to translating innovation into clinical value and providing patients with best-in-class treatments. The company has built a pipeline tiered as "1 (NDA) plus 3 (Phase III) plus N," and has preliminarily achieved innovation funding research and development through global business development licensing or transfers. As of the prospectus filing date, it has 10 major drug candidates under development targeting oncology, anti-infection, and other disease areas with significant market potential. The company projects net losses attributable to parent shareholders of between 349 million and 386 million yuan for the first three quarters of 2026.